Researchers from England have shown that unexpected bowel abnormalities in
children with regressive autism may have a basis in autoimmunity.
The authors used a panel of monoclonal antibodies to study small bowel
biopsies from children with autism in comparison to unaffected children with
other diseases.
The abnormalities were distinct from previously reported conditions, pointing
to the gut epithelium as a target of a specific immune response.
This finding suggests that autism may be an autoimmune disorder.
The work was performed by researchers at the Centre for Paediatric
Gastroenterology, with the Inflammatory Bowel Disease Study Group, Royal Free &
University College Medical School, London, UK; The IBD Research Unit, St. Mark's
Hospital, Harrow, London, UK; Department of Medicine, Royal Free and University
College Medical School, London, UK; Department of Histopathology, Royal Free and
University College Medical School, London, UK.
It remains unclear whether autism is a single disease or a condition
occurring as an end result of various abnormalities. Fundamental uncertainty
remains about the relative input of genetic predisposition and environmental
exposures.
Central to this uncertainty is the conflicting evidence concerning the
incidence of autism. While there are several reports of rapid increase in
incidence in Western countries -- suggesting an important environmental
component -- others suggest that the increase is more apparent than real, and
dependent on increased recognition, thus favoring a primarily genetic
predisposition.
Most research has focused on the genetics of autism, and several genes have
been implicated in classic autism.
This study is based on children with a form of autism characterized by
regression in the second year of life, after apparently normal early
development.
Most reports of immunological abnormalities in autistic children have been
from this subgroup of affected children, and the authors cite the increasing
body of evidence for abnormal immune regulation and autoimmunity in autism.
The initial observation of unexpected bowel pathology in autistic children
came from the same group, and centered on pathology in the colon (Lancet 1998;
351: 637-641, American Journal of Gastroenterology 2000; 95: 2285-2295).
Use of immunohistochemical techniques had suggested a novel form of colitis,
in which the epithelium of the colon was particularly affected (Journal of
Pediatrics 2001; 138: 366-372), and, thus, possibly suggestive of autoimmunity.
In the current study, the authors report a highly unusual form of small bowel
abnormality, subtle on routine staining, but with distinct and apparent
autoimmune features.
Again the epithelium appears to be the focus of this immune response, with
evidence of direct binding of self antibody to the surface of the epithelial
cells (enterocytes), increased epithelial division and infiltration of T
lymphocytes.
The authors used an extensive panel of monoclonal antibodies, and made
comparisons to children with celiac disease, cerebral palsy and mental
retardation, and apparently normal controls, none of whom showed this pattern of
abnormalities.
The findings thus support an autoimmune basis for the unexpected bowel
abnormalities in children with autism.
Many questions remain, in particular, the relevance of these findings to the
general autistic population, as these children had more obvious bowel symptoms
than commonly seen.
The authors avoid a direct suggestion that these bowel findings may be causal
in autistic regression, but they cite reports that cognitive function is
enhanced in some children with regressive autism when gut-based therapy is
introduced.
They also raise the possibility that the bowel changes may be a manifestation
of a primarily genetic condition affecting several systems in which disturbance
of brain function is simply more apparent.
Further work thus clearly needs to be done to determine the role of the
"gut-brain axis" in autism. However, confirmation that autoimmune responses
really do contribute to cognitive regression in autistic children will raise the
probability of a fundamental change in the treatment of autistic regression,
based on modulating the immune response in children with early autistic
symptoms.
An accompanying editorial further discusses this work and its implications
("Autoimmunity in Autism," by J Licinio, I Alvarado, and Ma-Li Wong, Molecular
Psychiatry 2002 Volume 7, number 4, page 329.) Molecular Psychiatry <
http://www.nature.com/mp>
is published by the Nature Publishing Group. Its editor is Julio Licinio, M.D.
(Reference: "Small intestinal enteropathy with epithelial IgG and complement
deposition in children with regressive autism;" F Torrente, P Ashwood, R Day, N
Machado, RI Furlano, A Anthony, SE Davies, AJ Wakefield, MA Thompson, JA
Walker-Smith and SH Murch, Molecular Psychiatry 2002 Volume 7, number 4, pages
375-382.)
* * *
Mercury Fills May Be Ailing Dentists
Dentists had excess mercury in their urine and nails: study
A study of 180 dentists by researchers at the Glasgow Royal Infirmary in
Scotland found they had up to four times the normal level of mercury in their
urine and nails and had more kidney disorders and memory lapses than the general
public.
We found several differences in the health and cognitive functioning between
our dentists and the control group, Dr. Ewan Macdonald said in a report in the
Journal of Occupational and Environmental Medicine.
These differences could not be directly attributed to their exposure to
mercury, but as mercury exposure at higher levels is known to cause similar
health effects an association cannot be ruled out, he added.
Mercury has been used in dentistry for about 150 years but some dentists and
researchers believe the fillings can give off harmful vapors that can be
dangerous for dentists and patients.
Critics of the fillings claim the mercury can poison the body and lead to
health problems affecting the kidneys and other organs and neurological diseases
such as Alzheimers.
But dental associations say it is safe when mixed with other metals and there
are no scientific studies to prove a link between the filling and health
problems.
The researchers in Glasgow compared mercury levels in urine, hair and nail
samples and the results of psychomotor skills, response times, word recall and
health problems of the 180 dentists and an equal number of volunteers.
The dentists had higher levels of the metal in their bodies, reported more
health problems and did worse on the tests than the volunteers.
The prevalence of self reported renal disease and memory disorders reflects
other reports and suggests that these may be occupationally
PRNewswire-FirstCall via COMTEX - Cortex Pharmaceuticals, Inc, today
announced that the company is collaborating with several research organizations
to carry out a phase II clinical study to evaluate one of the company's
AMPAKINE(R) compounds as a potential treatment for fragile X syndrome and
autism. Organizations participating in the study include the FRAXA Research
Foundation, Rush-Presbyterian-St. Luke's Medical Center in Chicago, and the
Child and Adolescent Psychiatry Department at the University of Chicago.
"We're very excited about this," said Vincent F. Simmon, Ph.D., President and
CEO of Cortex. "Currently there are no therapies on the market to treat fragile
X syndrome or autism. However, in the past five years, basic research has led to
an improved understanding of these diseases and a number of scientists have
suggested that the use of a drug to enhance glutamate transmission could be
beneficial. Our AMPAKINE compounds have been proven to enhance glutamate
transmission and therefore are obvious candidates as potential new therapeutics.
Cortex has not licensed these indications and retains full rights in the U.S.
and abroad."
About Fragile X Syndrome
Fragile X is an inherited disorder and is the most common cause of inherited
mental retardation, affecting 1 in 2,000 males and 1 in 4,000 females. Symptoms
of fragile X syndrome include mental impairment ranging from learning
disabilities to mental retardation, attention deficit and hyperactivity, anxiety
and unstable mood, autistic-like behaviors, long face, large ears, flat feet,
and hyperextensible joints, especially fingers.
Males are typically more severely affected than females. Although most males
have mental retardation, only one-third to one-half of females have significant
intellectual impairment; the rest have either normal IQ or learning
disabilities. Emotional and behavioral problems are common in both sexes.
Currently there are no therapeutic treatments for the disease, although
medications are used to treat some symptoms.
Rationale for the Study
A variety of scientific evidence suggests that increasing glutamate neuronal
transmission may be beneficial in autism and fragile X syndrome. Imaging studies
demonstrate that areas of the brain that are extremely rich in glutamate
transmission are less active in autistic patients. Molecular studies suggest
that although genes involved in the AMPA-type glutamate receptor are more active
in autistic patients, the density of AMPA-type glutamate receptors is decreased.
Drugs that reduce glutamatergic transmission induce symptoms similar to those
seen in autistic patients. Taken together, these facts suggest that enhancing
AMPA receptor activity may be beneficial in autistic patients.
The scientific logic for using a positive modulator in fragile X is more
complex but equally compelling. The genetic defect results in the reduction or
absence of an important protein, FMRP. FMRP is believed to play an important
role in allowing normal levels of AMPA receptor proteins to be made. Thus
increasing the activity of AMPA receptors with an AMPAKINE may to some degree
overcome the reduced number of AMPA receptors. FRAXA has previously funded a
study of AMPAKINE molecules in fragile X mice.
The design of the Phase II clinical study is a randomized double-blind,
placebo controlled trial lasting four weeks after a one-week placebo run-in and
ending with a two-week washout period. 50 patients from the Chicago area will be
recruited for the study. It is anticipated that enrollment will occur over a
two-year period. Outcome measures will include testing in four domains:
-- Attention and executive function
-- Spatial and verbal/auditory memory
-- Language domain
-- Behavior domain
Copyright (C) 2002 PR Newswire. All rights reserved.
* * *
Letters to Time Magazine on Their Coverage of Autism
Any time the incidence of a disease rises ten-fold; there is cause for alarm.
When that disease disables hundreds of thousands of children in a silent
holocaust, that sounds more like a national emergency. But autism remains a
footnote in NIH funding of disease research while the CDC cannot be bothered to
count the national incidence. Increases like this must come from somewhere. Why
aren't we more consumed with the search?
The answer is complicated. Most experts are preoccupied with autism's genetic
causes. Not surprising in the age of the genome, but an inquiry of marginal
relevance in the face of such dramatic increases. Most parents prefer straighter
arguments. You mention the vaccine concerns and cite the MMR theory but fail to
mention an even more plausible hypothesis, the increased exposure to mercury via
three different vaccines: DPT, haemophilus influenza B and hepatitis B. All
three contained the preservative Thimerosal (made from 49.6% mercury); the last
two were added to the childhood schedule in October 1990 and November 1991,
respectively.
When mercury exposure in these vaccines increased, the incidence of autism
went straight up. This could be coincidence, but mercury is a well-known and
potent neurotoxin, especially in the developing brain. Authorities realized in
1999 (oops!) that the cumulative vaccine dose of mercury exceeded EPA
guidelines, particularly in the earliest months of life. Soon after, they halted
new production and suspended the infant birth dose of hep B. No question, the
mercury hypothesis fits the evidence. But there is, as yet, no credible
investigation of the case. Why? Probably because discovering that policies
designed to protect children actually harmed them would be, to say the least,
inconvenient. And autism may be the tip of an iceberg of developmental delay.
But if the shoe fits, we must all wear it: inconvenience should not block
pursuit of the truth, wherever it leads.
Sincerely, Mark F. Blaxill
Cambridge MA (father of an autistic child and Board member of SafeMinds,
Sensible Action for Ending Mercury Induced Neurological Disorders)
There is Still More to Come
Four and a half years ago, I had no idea what autism was. I didn't need to
know, because I never thought that I could be touched by it. As a single mother
of a 2-year-old boy, I was struggling just to learn how to be a good mom. In
January 1998, my life changed forever when I was told why my son Henry didn't
speak. Why he threw violent temper tantrums. Why he seemed so odd.
Finding out that he had autism nearly destroyed me. Finding out that
he is part of a horrible trend didn't make it any easier. Today, at age 6
and a half, he still has never called me "mom" and has never uttered a word.
There are too many little boys just like him out there, too many to still come.
Thank you for your autism cover story.
Jill Briggs
San Antonio, TX
On the morning of April 29th, I picked up the May 6th issue of TIME, and read
every word of the article "The Secrets of Autism" along with the "First Person"
accounts included in the report.
To me, Time's Asia editor Karl Taro Greenfield and Time's head arts reporter
Amy Lennard Goehner in their "First Person" accounts exemplified the
Unconditional Love that is so often felt, within families, for those in the
Autistic spectrum. I learned from what I read, and felt satisfied, that the
population-at-large could be educated in regards to what we as families endure,
living with Autism. As parents of a 3 year old son with the condition, we have
the opportunity to experience life with Autism, living somewhat in a World
Apart, from neighbors and extended families that do not directly experience
Autism on a daily perpetual basis.
I sent a letter to the TIME Editor noting that Autism in the year 2002 does
not experience the same wide level of grassroots public support that benefits
fundraising for research dollars, nor does it extract the same level of public
empathy, for those suffering from AIDS, Breast Cancer, Parkinson's, Alzheimer's
and so many other unfortunate maladies.
Rather, parents who are now just learning that their toddler has autism, are
forced not only to confront the illness and its regressive effects on their
child, but also must now act aggressively with local public health and education
systems in states throughout the US, in order to obtain timely treatments that
have been proven effective. I also stated that while the present system does
recognize the benefits of Early Intervention, it does not effectively enforce
the application of Early Intervention in thousands of cases nationwide.
It is important to increase awareness among others disaffected by Autism, of
Autism's realities. Many are unaware that, regretfully, it is entirely too
common for many parents in our state of New Jersey, to turn towards litigation
to enforce the principles of the IDEA, enabling special needs students the
opportunity to receive an appropriate education that may very well remediate the
symptoms of Autism. Nationwide, school districts routinely oppose parents'
efforts to treat these children by implicitly encouraging less treatment than
medically prescribed, or explicitly pursuing placements in Less Expensive
programs that are themselves appropriate only for a percentage of the students
with autism.
Having said this, I am sure that TIME's cover story will serve to better
educate the public and hopefully lead to greater compassion for those suffering
from Autism and greater empathy for those families that count autism as a
central component of their lives - if we continue to Advocate for All of those
on the spectrum, not just our loved ones.
Adnan Shamsi
Father of Irteza, born 2/11/99
>>> What You Can Do Raise Autism Awareness: <<<
This is an opportunity to build upon the public awareness that is generated
by such prominent coverage, if you think it important. Why is autism awareness
so important? Because your neighbors, the government, the schools cannot help
solve a problem they don't know about.
* WRITE A LETTER - If you haven't already, to Time Magazine and let them know
your appreciation for their coverage: daily@timeinc.net. Make sure you send a
copy to FEAT: news@feat.org
* REVERSE BOYCOTT: BUY THEM UP. Send a message. The magazine is now out on
the stands. Buy as many as you can afford, then pass them around to friends and
neighbors. Brisk sales are a feedback to which they pay attention.
* BECOME A PUBLICITY HOUND. Call up all your local media news departments and
suggest to them there is a local angle to this national hot
subject: your story. Try newspaper editors first. If successful, you will
have an article to send to TV and radio news sources as prove the topic is
newsworthy. Then let us know, too.
Koren Boggs makes the one-and-a-half hour commute to DeSoto County from her
Oxford home at least two days a week and sometimes more, depending upon when
she's needed.
When you work with autistic children, you've got to go the extra mile, said
the 25-year-old Boggs.
The University of Mississippi graduate student is an intern with the school
system's autism early intervention education program. She is one of three Ole
Miss interns in the school system this year funded through the DeSoto County
School system and by the annual "Give A Kid A Chance To Be A Kid" Celebrity Golf
Tournament.
"These kids are amazing," said Boggs, a behavior specialist with the DeSoto
County School System, hired last year to work with autistic children. "They have
this amazing potential which is often overlooked."
Every program has a success story and Boggs said she has her own favorite.
"There is one little boy who has started to talk and be more interactive," said
Boggs. "He was completely non-verbal at the beginning of the year. When he
realized there was a value to communication using words with gestures because he
could get the object he wanted, he began a complete transformation."
Boggs said there are some students with Asperger's Syndrome, a higher
functioning form of autism. These students, such as 8-year-old Joshua Hammons of
Horn Lake, often do better than other children.
Joshua, who attends Walls Elementary School, is an avid reader, smiles
appropriately and understands conversations-yet, he did not take his first steps
until he was 18 1/2 months old. His mother, Rhonda Hammons, said Joshua was
originally misdiagnosed as having Attention Deficit Disorder.
"He had trouble learning anything until they (DeSoto school officials) put
him into the autistic program. That's when his whole turnaround began."
Joshua has had to undergo speech therapy from the time he was nearly 3. "He
still has some problems with words but in video games, he is really brilliant."
Having an autistic child in the family can be tough on parents and siblings
alike.
Justin Hammons, 11, is Joshua's older brother and says approvingly, "He loves
books, boats and planes. But he's gotten used to sitting in the front seat and
if he doesn't get to sit in the front seat, he pitches a fit."
Rhonda Hammons said behavior problems with autistic children are often the
most difficult to understand and comprehend. "People who don't know him think
he's spoiled. He's not. He just goes in his room, pitches a fit once a week and
then he's fine for the rest of the week." Hammons said families of autistic
children learn to deal with outbursts and temper tantrums.
Dr. Lynn Crain, director of special education for the DeSoto County School
system, said there is no known cause for autism but its numbers have increased
exponentially over the past decade, not only in the United States but in Great
Britain and the rest of Europe.
"Some people say we are just identifying more people but I don't think that's
the whole answer," said Crain.
Childhood vaccinations are being investigated as a possible cause and dietary
habits are now being looked at as a link to chemical imbalances and a way to
improve behavior.
Whatever the cause or treatment, the DeSoto County School system is being
looked to as a pioneering program in the Mid-South, she said.
And the program in DeSoto County started as the result of one child.
"We had one child move in who had autism and we sent one of instructors, Gwen
McGee, to North Carolina for training and she began to learn more and more about
autism," Crain said. "That was six years ago. We believe in training. Now we
have some teacher assistants who know as much about autism as many of the
experts."
Boggs said the faculty at Ole Miss recognizes the work being done in DeSoto
County as ground breaking.
"I would definitely say it's a model program," Boggs said. "All of the
parents who I've spoken to said it's really comforting to them to see someone
who has a strong desire to see their children succeed."
Registration for Concord AYSO VIP soccer on May 4, El Dorado Middle School.
Families with kids who have autism or ASD from ages 4-18 are encouraged to sign
up. Teams limited to kids with special needs. Players may also compete in
Special Olympics events. David LaDue, Director VIP program, dladue@astound.net
or 925-798-5956.
******
Seeking Speech/Language Therapist (or graduate student) to be key player in a
new, one-week summer camp program for Asperger's children (ages 9 - 12) in the
Philadelphia suburbs. Camp to focus on social skills, teamwork, problem-solving,
and fun academic pursuits. Please respond to Nelle219@aol.com.
******
Looking for an aba therapist to work with a 4yr old boy w/ autism in Malden,
Mass. this August Diane at dksullivan@attbi.com
******
I am looking for a summer camp for my teenage son. He is 18 and has High-Fuctioning
Autism/Aspergers. Looking for a program that meets the social needs of teens and
young adults with ASD. We live in southern CA, but would be happy to hear of any
good program, anywhere. Thanks. Emily emilyiland@socal.rr.com
******
Amherst, Mass: I'm looking for a female to live rent-free in my home (she
gets her own large bedroom and private bath) in exchange to 10-12 hours of
babysitting weekly for 5-year-old boy with Asperger's Syndrome. A love of
children and an interest in learning about A.S. are necessary. Contact me at
lwentwo@crocker.com.
******
We have a 4.5 yo son with ASD, we just started using Super Nu-thera. Is
anyone out there using SNT and have you had any positive results? KJSeile@hotmail.com
******
If you are part of a parent group trying to get services for your child,
sharing resources, offering support, etc. or know of such a group, please send
to this newsletter the group's name, an overland mail address and a phone
number. Some autism groups are building a nationwide advocacy network and
everyone doing advocacy needs to be plugged in. Important - Contact Lenny
Schafer at editor@feat.org
******
Looking for information and someone offering training in our area on Lovaas
and ABA therapy. We live in southern Indiana. Austin is eleven and have tried
many hospitals and trainings. Please email april_hoke@hotmail.com or april@pentusa.com.
April
******
Why is the pertusis vaccine not in question? Why the drugs given to women in
labour and the actual labour scenarios are not being looked at as a possible
reason for the increased numbers of children affected with aspergers and PDD or
autism? In my small group of aquaintances and friends, we have an outragiously
large proportion of children affected with one or another of these disorders. In
my children's school we have a very high incidence as well. This is not genetic.
If you are interested in contacting me, e-mail monarv@rogers.com
******
>> FREE (Almost) READERS POSTS <<
For individuals, organizations, non-commercial and
commercial. Limit your posting to no more than 60
words please. There is no charge for this service,
but posters are obligated to thank all those who take
the time to answer your ads. This is a consideration
for others with autism after you and yours, who seek
assistance from appreciated readers. Send submissions to:
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"